DCPC 230008 - National Comprehensive Cancer Control Program Evaluation (2022 - 2027)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Centers for Disease Control and Prevention is seeking to execute a five-year evaluation of the National Comprehensive Cancer Control Program from 2022 to 2027, aiming to enhance program effectiveness through a utilization-focused approach. This initiative will engage CDC staff, comprehensive cancer control program practitioners, and their partners to generate practical insights that inform decision-making and drive measurable improvements. The evaluation is designed to assess program capacity, clearly define outcomes, and uncover critical lessons learned to support long-term growth and sustainability. The contract, classified under NAICS code 541690, is forecasted with a posted date of May 25, 2026, and is managed by the CDC’s Office of Disease Prevention and Health Promotion. Angela Moore serves as the Program Point of Contact, with the Contracting Officer position still to be determined. The project will not be limited by geographic constraints, as the place of performance is unspecified, allowing for nationwide collaboration. The ultimate goal is to produce actionable, evidence-based findings that enable stakeholders to strengthen their cancer control efforts and ensure the program remains adaptive, responsive, and effective in reducing cancer-related burden across communities.
General Info
Agency
NAICS
Place of Performance
USSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
